VACC NASDAQ
Vaccitech plc
1W: +6.8%
1M: -29.5%
3M: +54.4%
1Y: +40.6%
$5.00
Last traded 2023-12-01 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
+0.0% ▲
Operating Income
$506K
-57.0% ▼
Net Income
-$66M
-8.8% ▼
EPS (Diluted)
$-1.64
-5.8% ▼
EBITDA
$506K
-57.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5M | $268K | $45M | $15M | $0 |
| YoY Growth | -29.6% | -94.4% | +16580.2% | +0.0% | -100.0% |
| Cost of Revenue | $14M | $20M | $42M | $0 | $0 |
| Gross Profit | -$10M | -$20M | $2M | $0 | $0 |
| Gross Margin | -198.5% | -7501.1% | 5.3% | 0.0% | — |
| R&D Expenses | $11M | $16M | $41M | $42M | $26M |
| SG&A Expenses | $10M | $25M | $6M | $30M | $41M |
| Operating Expenses | $22M | $41M | $48M | $84M | $71M |
| Operating Income | -$20M | -$45M | -$3M | $1M | $506K |
| Operating Margin | -415.9% | -16873.5% | -7.7% | 7.9% | — |
| Interest Expense | $4M | $3M | $19K | -$53K | -$51K |
| Income Before Tax | -$18M | -$51M | $850K | -$61M | -$67M |
| Tax Expense | $95K | -$28K | -$4M | -$153K | -$205K |
| Net Income | -$18M | -$51M | $5M | -$61M | -$66M |
| Net Margin | -372.0% | -19071.6% | 11.9% | -408.0% | — |
| EPS (Diluted) | $-2.27 | $-1.97 | $0.14 | $-1.55 | $-1.64 |
| EBITDA | -$17M | -$45M | $5M | $1M | $506K |
| Shares Outstanding | 8M | 26M | 38M | 39M | 41M |